Scientists at EPFL and AstraZeneca have developed a method to map the atomic-level structure of amorphous drugs, demonstrated on a GLP-1 receptor agonist candidate for diabetes and obesity treatment.
The schematic diagram reveals that the stabilizing effect of iridium single atoms during the acidic oxygen evolution reaction is determined by their anchoring sites. Single atoms anchored at lattice ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results